GlassScriptPhysician profile
William Tenpenny
NPI 1861802589
$54,636.44
in general payments reported to CMS, 2019-2025
13 companies · $187 in 2025
The $187 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43K · 2020: $7,154 · 2021: $1,243 · 2022: $2,495 · 2023: $60.57 · 2024: $307 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $554.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $554.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $20,475.82 | 2019 | |
| Acumed LLC | $15,000.00 | 2019 | |
| Fortis Surgical, LLC | $5,665.22 | 2019 | |
| Linvatec Corporation | $5,000.00 | 2020 | |
| Novus Surgical Solutions LLC | $4,295.40 | 2020-2022 | |
| Smith+Nephew, INC. | $3,018.46 | 2019-2023 | Bone Anchors With Arthroscopic Delivery System |
| Stryker Corporation | $372.72 | 2019-2025 | Mako, Trident, Triathlon |
| Novus Surgical Consultants | $298.92 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $173.12 | 2019 | |
| Depuy Synthes Sales INC. | $126.46 | 2019 | |
| Vericel Corporation | $115.38 | 2019 | |
| Medical Device Business Services, INC. | $71.00 | 2019-2020 | |
| Ermi LLC | $23.94 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Tenpenny listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.